Overview of Development and Formulation of ¹⁷⁷Lu-DOTA-TATE for PRRT

E-ISSN： 1874-4729|9|1|8-18

ISSN： 1874-4710

Source： Current Radiopharmaceuticals, Vol.9, Iss.1, 2015-11, pp. : 8-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Standardization of Procedures for the Preparation of ¹⁷⁷Lu- and ⁹⁰Y-labeled DOTA-Rituximab Based on the Freeze-dried Kit Formulation

Current Radiopharmaceuticals, Vol. 8, Iss. 1, 2015-05 ,pp. : 62-68

Bentham Science Publishers

Access to resources Recommend Favorite

Accurate assessment of whole-body retention for PRRT with ¹⁷⁷Lu using paired measurements with external detectors

Current Radiopharmaceuticals, Vol. 8, Iss. 2, 2015-08 ,pp. : 129-138

Bentham Science Publishers

Access to resources Recommend Favorite

Radiation Dosimetry Aspects of ¹⁷⁷Lu

Current Radiopharmaceuticals, Vol. 8, Iss. 2, 2015-08 ,pp. : 139-144

Bentham Science Publishers

Access to resources Recommend Favorite

Consequences of meta-stable ^177mLu admixture in ¹⁷⁷Lu for patient dosimetry

Current Radiopharmaceuticals, Vol. 8, Iss. 2, 2015-08 ,pp. : 145-149

Bentham Science Publishers

Access to resources Recommend Favorite

Alternative method to determine Specific Activity of ¹⁷⁷Lu by HPLC

Current Radiopharmaceuticals, Vol. 8, Iss. 2, 2015-08 ,pp. : 119-122

Bentham Science Publishers

Access to resources Recommend Favorite